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background: Parvovirus B19 infections are acquired by majority in the childhood and persist lifelong within bone marrow precursor cells and 
the vascular endothelium in a high percentage of the general population. Because many infected patients remain asymptomatic, the clinical has 
remained doubtful.
Methods: The study group comprised of 423 consecutive parvovirus positive and 177 virus negative patients (441 man, mean age 53.0±12.6 
years) presenting with symptomatic heart failure and global systolic left ventricular dysfunction below 45% (mean EF 29.5±8.9%). The patients who 
clinically presented as suspected myocarditis (n=310) or dilated cardiomyopathy (n=290) were followed for 60 months to compare outcome with 
respect to biopsy-based quantitative information on myocardial inflammation and virus infection.
results: Biopsy analyses confirmed myocarditis and inflammatory cardiomyopathy in 37.6% and 27%, respectively with comparable numbers 
of inflammatory cells in virus negative and positive patients. Five year survival was impaired in B19V positive patients if infiltrating CD3-positive 
lymphocytes exceeded 10 cells/mm2 (p<0.001) whereas mortality was not associated with elevated inflammatory cells in virus negative patients 
(p=0.837).
conclusions: Inflammatory cardiomyopathy in the presence of B19V infection is associated with a higher mortality than in patients with non 
infectious myocardial inflammation. Endothelial cell infection may constitute a cofactor that aggravates inflammatory cell associated myocardial 
outcome.
